• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 3 filed by new insider Simmermacher Ezequiel

    4/20/26 2:48:14 PM ET
    $BIOX
    Agricultural Chemicals
    Industrials
    Get the next $BIOX alert in real time by email
    SEC FORM 3SEC Form 3
    FORM 3UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

    Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
    or Section 30(h) of the Investment Company Act of 1940
    OMB APPROVAL
    OMB Number:3235-0104
    Estimated average burden
    hours per response:0.5
    1. Name and Address of Reporting Person*
    Simmermacher Ezequiel

    (Last)(First)(Middle)
    CALLE 64 S/N

    (Street)
    PILARBUENOS AIRES1629

    (City)(State)(Zip)

    ARGENTINA

    (Country)
    2. Date of Event Requiring Statement (Month/Day/Year)
    12/31/2025
    3. Issuer Name and Ticker or Trading Symbol
    Bioceres Crop Solutions Corp. [ BIOX ]
    3a. Foreign Trading Symbol
    5. If Amendment, Date of Original Filed (Month/Day/Year)
    4. Relationship of Reporting Person(s) to Issuer
    (Check all applicable)
    Director10% Owner
    XOfficer (give title below)Other (specify below)
    CFO
    6. Individual or Joint/Group Filing (Check Applicable Line)
    XForm filed by One Reporting Person
    Form filed by More than One Reporting Person
    Table I - Non-Derivative Securities Beneficially Owned
    1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
    Table II - Derivative Securities Beneficially Owned
    (e.g., puts, calls, warrants, options, convertible securities)
    1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year)3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
    Date ExercisableExpiration DateTitleAmount or Number of Shares
    Explanation of Responses:
    No securities are beneficially owned.
    /s/ Ezequiel Simmermacher04/20/2026
    ** Signature of Reporting PersonDate
    Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
    * If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
    ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
    Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    * Form 3: SEC 1473 (03-26)
    Get the next $BIOX alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $BIOX

    DatePrice TargetRatingAnalyst
    10/22/2025Outperform → Perform
    Oppenheimer
    9/10/2025$2.50Buy → Hold
    Canaccord Genuity
    7/19/2024$17.00Buy
    Canaccord Genuity
    7/2/2024$15.00Buy
    ROTH MKM
    4/6/2023$15.00Outperform
    Oppenheimer
    9/30/2022$22.50Buy
    Canaccord Genuity
    10/8/2021$21.00Buy
    ROTH Capital
    More analyst ratings

    $BIOX
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 3 filed by new insider Simmermacher Ezequiel

    3 - Bioceres Crop Solutions Corp. (0001769484) (Issuer)

    4/20/26 2:48:14 PM ET
    $BIOX
    Agricultural Chemicals
    Industrials

    $BIOX
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    A Message from Our Chief Executive Officer

      Bioceres Crop Solutions Corp. (NASDAQ:BIOX): Dear Fellow Shareholders, This communication accompanies the filing of our Form 6-K for the second quarter of fiscal year 2026, covering the six-month period ended 31 December 2025. I want to speak directly to our shareholders about where we stand, what we are focused on, and how we are navigating a period that has been both challenging and clarifying for Bioceres. OUR CONTINUING BUSINESS — FOCUS AND DIRECTION The financial results for this quarter reflect a difficult external environment — most notably, sustained pressure on Argentine farmer economics driven by commodity price weakness and the well-documented tightening of credit con

    3/16/26 7:30:00 AM ET
    $BIOX
    Agricultural Chemicals
    Industrials

    Bioceres Crop Solutions Reports Fiscal First Quarter 2026 Financial and Operational Results

    Total revenues were $77.5 million in 1Q26 Net loss was $7.5 million and Adjusted EBITDA1 was $13.6 million Bioceres Crop Solutions Corp. (Bioceres) (NASDAQ:BIOX), a leader in the development and commercialization of productivity solutions designed to regenerate agricultural ecosystems while making crops more resilient to climate change, announced financial results for the fiscal first quarter ended September 30, 2025. Financial results are expressed in U.S. dollars and are presented in accordance with International Financial Reporting Standards. All comparisons in this announcement are year-over-year (YoY), unless otherwise noted. Financial & Business Highlights Total revenues were

    11/12/25 5:15:00 PM ET
    $BIOX
    Agricultural Chemicals
    Industrials

    Bioceres Crop Solutions to Host Fiscal First Quarter 2026 Financial Results Conference Call on Thursday, November 13, 2025 at 8:30 a.m. Eastern Time

    Bioceres Crop Solutions Corp. (NASDAQ:BIOX) ("Bioceres" or the "Company"), a leader in the development and commercialization of productivity solutions designed to regenerate agricultural ecosystems while making crops more resilient to climate change, will hold a conference call on Thursday, November 13, 2025 at 8:30 a.m. Eastern Time to discuss its results for the fiscal first quarter ended September 30, 2025. A press release detailing these results will be issued prior to the call. Bioceres Chairman & Chief Executive Officer Federico Trucco and Head of Investor Relations Paula Savanti will host the conference call, followed by a question-and-answer session. The conference call will be ac

    10/30/25 8:30:00 AM ET
    $BIOX
    Agricultural Chemicals
    Industrials

    $BIOX
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Bioceres downgraded by Oppenheimer

    Oppenheimer downgraded Bioceres from Outperform to Perform

    10/22/25 10:10:01 AM ET
    $BIOX
    Agricultural Chemicals
    Industrials

    Bioceres downgraded by Canaccord Genuity with a new price target

    Canaccord Genuity downgraded Bioceres from Buy to Hold and set a new price target of $2.50

    9/10/25 7:58:04 AM ET
    $BIOX
    Agricultural Chemicals
    Industrials

    Canaccord Genuity resumed coverage on Bioceres with a new price target

    Canaccord Genuity resumed coverage of Bioceres with a rating of Buy and set a new price target of $17.00

    7/19/24 8:32:10 AM ET
    $BIOX
    Agricultural Chemicals
    Industrials

    $BIOX
    SEC Filings

    View All

    SEC Form 6-K filed by Bioceres Crop Solutions Corp.

    6-K - Bioceres Crop Solutions Corp. (0001769484) (Filer)

    3/17/26 9:16:47 AM ET
    $BIOX
    Agricultural Chemicals
    Industrials

    SEC Form 6-K filed by Bioceres Crop Solutions Corp.

    6-K - Bioceres Crop Solutions Corp. (0001769484) (Filer)

    3/16/26 9:48:43 PM ET
    $BIOX
    Agricultural Chemicals
    Industrials

    SEC Form 6-K filed by Bioceres Crop Solutions Corp.

    6-K - Bioceres Crop Solutions Corp. (0001769484) (Filer)

    3/13/26 5:23:59 PM ET
    $BIOX
    Agricultural Chemicals
    Industrials

    $BIOX
    Financials

    Live finance-specific insights

    View All

    Bioceres Crop Solutions Reports Fiscal First Quarter 2026 Financial and Operational Results

    Total revenues were $77.5 million in 1Q26 Net loss was $7.5 million and Adjusted EBITDA1 was $13.6 million Bioceres Crop Solutions Corp. (Bioceres) (NASDAQ:BIOX), a leader in the development and commercialization of productivity solutions designed to regenerate agricultural ecosystems while making crops more resilient to climate change, announced financial results for the fiscal first quarter ended September 30, 2025. Financial results are expressed in U.S. dollars and are presented in accordance with International Financial Reporting Standards. All comparisons in this announcement are year-over-year (YoY), unless otherwise noted. Financial & Business Highlights Total revenues were

    11/12/25 5:15:00 PM ET
    $BIOX
    Agricultural Chemicals
    Industrials

    Bioceres Crop Solutions to Host Fiscal First Quarter 2026 Financial Results Conference Call on Thursday, November 13, 2025 at 8:30 a.m. Eastern Time

    Bioceres Crop Solutions Corp. (NASDAQ:BIOX) ("Bioceres" or the "Company"), a leader in the development and commercialization of productivity solutions designed to regenerate agricultural ecosystems while making crops more resilient to climate change, will hold a conference call on Thursday, November 13, 2025 at 8:30 a.m. Eastern Time to discuss its results for the fiscal first quarter ended September 30, 2025. A press release detailing these results will be issued prior to the call. Bioceres Chairman & Chief Executive Officer Federico Trucco and Head of Investor Relations Paula Savanti will host the conference call, followed by a question-and-answer session. The conference call will be ac

    10/30/25 8:30:00 AM ET
    $BIOX
    Agricultural Chemicals
    Industrials

    Bioceres Crop Solutions Reports Fiscal Fourth Quarter and Full-Year 2025 Financial and Operational Results

    Total revenues were $74.7 million in 4Q25 and $335.3 million in FY25 FY25 results reflect challenging year amid ag sector headwinds and macro pressures in Argentina Bioceres Crop Solutions Corp. (Bioceres) (NASDAQ:BIOX), a leader in the development and commercialization of productivity solutions designed to regenerate agricultural ecosystems while making crops more resilient to climate change, announced financial results for the fiscal fourth quarter ended June 30, 2025. Financial results are expressed in U.S. dollars and are presented in accordance with International Financial Reporting Standards. All comparisons in this announcement are year-over-year (YoY), unless otherwise noted.

    9/9/25 6:00:00 AM ET
    $BIOX
    Agricultural Chemicals
    Industrials

    $BIOX
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Bioceres Crop Solutions Corp.

    SC 13G - Bioceres Crop Solutions Corp. (0001769484) (Subject)

    10/23/24 2:32:38 PM ET
    $BIOX
    Agricultural Chemicals
    Industrials

    Amendment: SEC Form SC 13D/A filed by Bioceres Crop Solutions Corp.

    SC 13D/A - Bioceres Crop Solutions Corp. (0001769484) (Subject)

    9/20/24 9:09:41 PM ET
    $BIOX
    Agricultural Chemicals
    Industrials

    SEC Form SC 13D/A filed by Bioceres Crop Solutions Corp. (Amendment)

    SC 13D/A - Bioceres Crop Solutions Corp. (0001769484) (Subject)

    3/25/24 8:58:35 AM ET
    $BIOX
    Agricultural Chemicals
    Industrials